Bioventus Stock (NASDAQ: BVS) stock price, news, charts, stock research, profile.
Open | $6.200 |
Close | - |
Volume / Avg. | 71.637K / 242.012K |
Day Range | 6.070 - 6.260 |
52 Wk Range | 1.470 - 6.800 |
Market Cap | $390.625M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 66 |
Short Interest | 1.63% |
Days to Cover | 5.89 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Bioventus (NASDAQ: BVS) through any online brokerage.
Other companies in Bioventus’s space includes: Solventum (NYSE:SOLV), RxSight (NASDAQ:RXST), TELA Bio (NASDAQ:TELA), Embecta (NASDAQ:EMBC) and Align Tech (NASDAQ:ALGN).
The latest price target for Bioventus (NASDAQ: BVS) was reported by Canaccord Genuity on Wednesday, May 8, 2024. The analyst firm set a price target for 8.00 expecting BVS to rise to within 12 months (a possible 30.72% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Bioventus (NASDAQ: BVS) is $6.12 last updated Today at May 21, 2024 at 2:26 PM EDT.
There are no upcoming dividends for Bioventus.
Bioventus’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Bioventus.
Bioventus is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.